Alemtuzumab-cyclosporine versus tacrolimus-methotrexate-sirolimus for graft-versus-host disease prophylaxis in reduced intensity allogeneic hematopoietic stem cell transplantation from unrelated donors: Final results of a randomized trial Meeting Abstract


Authors: Curtis, L. M.; Pavletic, S. Z.; Salit, R. B.; Shaffer, B. C.; Steinberg, S. M.; Wilder, J. S.; Pirsl, F.; Blacklock-Schuver, B.; Hsu, J.; Hughes, T. E.; Stroncek, D.; Adams, S.; Hendricks, J.; Avila, D. N.; Mann, J.; Halverson, D. C.; Friedman, T. M.; Korngold, R.; Gea-Banacloche, J. C.; Fowler, D. H.; Confer, D. L.; Hakim, F. T.; Gress, R. E.; Bishop, M. R.
Abstract Title: Alemtuzumab-cyclosporine versus tacrolimus-methotrexate-sirolimus for graft-versus-host disease prophylaxis in reduced intensity allogeneic hematopoietic stem cell transplantation from unrelated donors: Final results of a randomized trial
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019000129
PROVIDER: wos
DOI: 10.1182/blood.V126.23.65.65
Notes: Meeting Abstract: 65 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Carl Shaffer
    165 Shaffer
Related MSK Work